MedPath

Vergleich der Effektivität von Insulin Aspart und Normalinsulin bei Typ 2 Diabetikern hinsichtlich des postprandialen Stoffwechsels während zwei aufeinanderfolgender Mahlzeiten. Die Huckepack Studie

Phase 1
Active, not recruiting
Conditions
Type-2 Diabetes treated with insulin
Registration Number
EUCTR2004-002455-13-AT
Lead Sponsor
Dept. of Internal Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Recruiting
Sex
All
Target Recruitment
14
Inclusion Criteria

Typ 2 Diabetes
BMI > 27 kg/m2
Treatment with insulin alone or in combination with metformin
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

HbA1c > 9.5 %
Serum Kreatinin > 1.7 mg/dl
ALT or AST > 3x ULN

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.